Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 12/20 | 0.52 |
| ▸ | FNTB | P49356 | 12/20 | 0.52 |
| ▸ | PGGT1B | P53609 | 2/20 | 0.52 |
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | DPP4 | P27487 | 4/20 | 0.32 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.32 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2177983 | 0.79 | FNTA (0.54) | FNTAFNTBPGGT1BIDO1 | |
| SCHEMBL7644048 | 0.78 | FNTA (0.52) | FNTAFNTBPGGT1BIDO1 | |
| SCHEMBL7091902 | 0.75 | FNTA (0.54) | FNTAFNTBPGGT1BIDO1 | |
| SCHEMBL7092843 | 0.74 | FNTA (0.53) | FNTAFNTBPGGT1BIDO1 | |
| SCHEMBL7092101 | 0.73 | IDO1 (0.46) | FNTAFNTBPGGT1BIDO1MAPK1 | |
| SCHEMBL7089905 | 0.73 | IDO1 (0.47) | FNTAFNTBPGGT1BIDO1MAPK1 | |
| SCHEMBL7091956 | 0.72 | IDO1 (0.47) | FNTAFNTBPGGT1BIDO1MAPK1 | |
| SCHEMBL7645087 | 0.72 | IDO1 (0.44) | FNTAFNTBPGGT1BIDO1MEN1 | |
| SCHEMBL7091512 | 0.71 | IDO1 (0.43) | FNTAFNTBPGGT1BIDO1MAPK1 | |
| SCHEMBL6554711 | 0.71 | FNTA (0.39) | FNTAFNTBPGGT1BMEN1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1390033-A1 | FARNESYL PROTEIN TRANSFERASE INHIBITORS FOR TREATING CACHEXIA | JANSSEN PHARMACEUTICA N.V. (BE) | 2004-02-25 | — | — | EP | claimed |
| EP-1255537-A2 | FARNESYL PROTEIN TRANSFERASE INHIBITORS FOR TREATING BREAST CANCER | JANSSEN PHARMACEUTICA N.V. (BE) | 2002-11-13 | — | — | EP | claimed |
| WO-2002085364-A1 | FARNESYL PROTEIN TRANSFERASE INHIBITORS FOR TREATING CACHEXIA | JANSSEN PHARMACEUTICA N.V. (BE) | 2002-10-31 | — | — | WO | claimed |
| WO-2001056552-A2 | FARNESYL PROTEIN TRANSFERASE INHIBITORS FOR TREATING BREAST CANCER | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-08-09 | — | — | WO | claimed |
| EP-1261341-A2 | FARNESYL PROTEIN TRANSFERASE INHIBITOR COMBINATIONS WITH CAMPTOTHECIN COMPOUNDS | JANSSEN PHARMACEUTICA N.V. (BE) | 2002-12-04 | — | — | EP | disclosed |
| WO-2001064194-A2 | FARNESYL PROTEIN TRANSFERASE INHIBITOR COMBINATIONS WITH CAMPTOTHECIN COMPOUNDS | JANSSEN PHARMACEUTICA N.V. (BE) | 2001-09-07 | — | — | WO | disclosed |